Caspase-2 has been reported to play a role in the cell death observed under a number of different conditions; however, it is unclear whether
caspase-2 plays a role in cell death triggered by endoplasmic reticulum (ER) stress. The purpose of this study was to determine whether
caspase-2 is involved in SH-SY5Y
neuroblastoma cell death caused by
thapsigargin-induced ER stress.
Thapsigargin treatment (1 microM, 16 hr) stimulated the proteolytic processing of caspases-2, -3, and -7, suggesting that these
caspases are activated by ER stress. The role of these
caspases in
thapsigargin-induced cell death was examined by using cell-permeable
caspase inhibitors. In the absence of pretreatment with
caspase inhibitors,
thapsigargin (0.1 microM, 20 hr) reduced the number of viable cells to 53.9% +/- 3.3% of starting-time control. Pretreatment for 90 min with either the pan-
caspase inhibitor
Z-VAD-FMK or the caspase-2-selective inhibitor
Z-VDVAD-FMK inhibited
thapsigargin-stimulated cell death, resulting in the number of viable cells being 115.6% +/- 5.3% (P < 0.001) and 69.3% +/- 2.9% (P < 0.01), respectively, of starting-time control. Neither the caspase-3- and -7-selective inhibitor
Z-DEVD-FMK nor the caspase-9-selective inhibitor
Z-LEHD-FMK significantly affected
thapsigargin-stimulated cell death. An anticaspase-12-reactive
protein was also identified in SH-SY5Y cells, but
thapsigargin had no effect on proteolysis of this
protein. These data demonstrate that caspases-2, -3, and -7 are involved in ER stress-mediated death of SH-SY5Y cells.